BiotechTube

Terbinafine hydrochloride

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Tinea Capitis

Conditions

Tinea Capitis

Trial Timeline

Jul 1, 2004 → Apr 1, 2006

NCT ID
NCT00117754

About Terbinafine hydrochloride

Terbinafine hydrochloride is a phase 3 stage product being developed by Novartis for Tinea Capitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00117754. Target conditions include Tinea Capitis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT00002394Pre-clinicalCompleted
NCT00117754Phase 3Completed

Competing Products

20 competing products in Tinea Capitis

See all competitors
ProductCompanyStageHype Score
Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle BSun PharmaceuticalPhase 1
33
Naftifine Hydrochloride Gel 2% + Naftin® Gel 2% + Placebo Topical GelSun PharmaceuticalPhase 1
33
Naftifine Hydrochloride Cream 2% + Naftin® (Naftifine Hydrochloride) Cream 2% + Placebo Topical CreamSun PharmaceuticalPhase 1
33
Butenafine Hydrochloride Cream, 1% + Lotrimin Ultra® + Butenafine VehicleSun PharmaceuticalPhase 1
33
Naftifine HCl Cream 1% + Naftin® (Naftifine HCl) Cream 1% + Placebo topical creamSun PharmaceuticalPhase 1
33
Ketoconazole Shampoo, 2% + Ketoconazole Shampoo, 2% (Reference Standard) + PlaceboSun PharmaceuticalPhase 1
33
TA103 + Placebo ControlSun PharmaceuticalPhase 1
33
Oxiconazole Nitrate Cream 1% + Oxiconazole Nitrate Cream 1% (Oxistat®) + PlaceboSun PharmaceuticalPhase 1
33
Butenafine cream 1% manufactured by Taro + Lotrimin Ultra (butenafine) 1% + Butenafine Vehicle manufactured by TaroSun PharmaceuticalPhase 1
33
Sertaconazole nitrate cream 2%Johnson & JohnsonPhase 3
77
Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)Johnson & JohnsonPhase 3
77
Terbinafine hydrochloride (HCl) + GriseofulvinNovartisPhase 3
77
Terbinafine + Terbinafine PlaceboNovartisPhase 3
77
fluconazolePfizerPhase 3
76
AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718PfizerPhase 1
32
W0027 + PlaceboGSK plcPhase 1
32
Bifonazole spray once daily + Bifonazole spray twice daily + Placebo + Placebo + Lamisil OnceBayerPhase 2
49
Econazole Nitrate Cream, 1% + PlaceboViatrisPhase 3
74
LAS41003 + LAS189961 + LAS189962AlmirallPhase 2
47
Luliconazole Cream 1% + Vehicle CreamBausch HealthApproved
80

Other Products from Novartis

LCZ696Approved
85
zoledronic acidApproved
85
NateglinideApproved
85
TenofovirApproved
85
FTY720Approved
85